BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$716M |
| 2 |
Apple
AAPL
|
+$677M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$561M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$554M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.85B |
| 2 |
Equinix
EQIX
|
+$2.31B |
| 3 |
Tesla
TSLA
|
+$2.3B |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$1.87B |
| 5 |
TRLA
TRULIA INC (DEL)
TRLA
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.77% |
| 2 | Financials | 3.07% |
| 3 | Industrials | 1.75% |
| 4 | Healthcare | 1.67% |
| 5 | Materials | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
226
DELISTED
Kellanova
K
| $16.6M | 0.02% |
269,255
-12,190
| -4% | -$763K |
|
227
Delta Air Lines
DAL
$59.3B
| $16.6M | 0.02% |
428,895
-104,971
| -20% | -$3.96M |
|
|
RSX
228
PUT
DELISTED
VanEck Russia ETF
RSX
| $16.4M | 0.02% |
591,714
+574,416
| +3,321% | +$14.1M |
|
229
Thermo Fisher Scientific
TMO
$220B
| $16.2M | 0.02% |
137,446
-27,524
| -17% | -$3.24M |
|
230
Netflix
NFLX
$314B
| $16.2M | 0.02% |
2,576,140
-2,405,760
| -48% | -$13M |
|
|
BRCM
231
DELISTED
BROADCOM CORP CL-A
BRCM
| $16.2M | 0.02% |
435,841
-503,446
| -54% | -$16.5M |
|
|
NS
232
DELISTED
NuStar Energy L.P.
NS
| $16.1M | 0.02% |
259,300
| – | – |
|
233
Phillips 66
PSX
$85B
| $16.1M | 0.02% |
199,627
-93,545
| -32% | -$7.71M |
|
234
Lowe's Companies
LOW
$122B
| $15.9M | 0.02% |
332,042
-223,601
| -40% | -$10.4M |
|
235
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.7B
| $15.9M | 0.01% |
476,002
-721,434
| -60% | -$23.4M |
|
236
NetApp
NTAP
$39.3B
| $15.9M | 0.01% |
434,518
-278,016
| -39% | -$9.96M |
|
237
Regeneron Pharmaceuticals
REGN
$82.8B
| $15.9M | 0.01% |
56,132
-41,537
| -43% | -$12.3M |
|
238
Eaton
ETN
$173B
| $15.8M | 0.01% |
205,035
-27,104
| -12% | -$2.01M |
|
239
PACCAR
PCAR
$69.6B
| $15.8M | 0.01% |
377,123
-262,918
| -41% | -$11.2M |
|
240
Molina Healthcare
MOH
$10.4B
| $15.8M | 0.01% |
353,843
-53,913
| -13% | -$2.19M |
|
241
Boston Scientific
BSX
$73.4B
| $15.8M | 0.01% |
1,234,323
-141,107
| -10% | -$1.83M |
|
242
EQT Corp
EQT
$33.5B
| $15.7M | 0.01% |
270,403
+151,867
| +128% | +$8.71M |
|
|
ICON
243
DELISTED
Iconix Brand Group, Inc.
ICON
| $15.7M | 0.01% |
36,574
+2,136
| +6% | +$881K |
|
|
CAM
244
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $15.7M | 0.01% |
231,292
-40,963
| -15% | -$2.64M |
|
|
TEF
245
DELISTED
Telefonica
TEF
| $15.6M | 0.01% |
1,239,687
| – | – |
|
246
SPDR Gold Trust
GLD
$142B
| $15.5M | 0.01% |
121,147
-8,097
| -6% | -$1.01M |
|
247
CALL
iShares Russell 2000 ETF
IWM
$81.4B
| $15.4M | 0.01% |
15,372
-26,598
| -63% | -$3.02M |
|
|
RSX
248
CALL
DELISTED
VanEck Russia ETF
RSX
| $15.4M | 0.01% |
584,933
+578,466
| +8,945% | +$14.2M |
|
|
PPL
249
PPL Corp
PPL
$26.4B
| $15.4M | 0.01% |
454,856
-35,106
| -7% | -$1.11M |
|
|
EXAS
250
DELISTED
Exact Sciences
EXAS
| $15.3M | 0.01% |
900,017
+900,007
| +9,000,070% | +$12.4M |
|
Similar funds
BNP Paribas Financial Markets's Q2 2014 Portfolio in Review
As of Q2 2014, BNP Paribas Financial Markets held 4,108 positions worth $106B, down 17% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets deployed $44.2B of net new capital in Q2 2014, opening 765 new positions and adding to 1,315 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $3.85B trimmed.
- BNP Paribas Financial Markets's largest Q2 2014 buy was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
- BNP Paribas Financial Markets added most to Potash Corp Of Saskatchewan in Q2 2014, an estimated $716M increase.
- BNP Paribas Financial Markets's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $3.85B.
- BNP Paribas Financial Markets fully exited Walter Investment Mgt Corp in Q2 2014, selling an estimated $477M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $106B portfolio in Q2 2014.
- BNP Paribas Financial Markets opened 765 new positions and closed 285 in Q2 2014.
- BNP Paribas Financial Markets's portfolio value fell 17% quarter-over-quarter to $106B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.